Literature DB >> 19735311

Haemopoietic stem cell transplantation induces tolerance to donor antigens but not to foreign FVIII peptides.

J Uprichard1, F Dazzi, J F Apperley, M A Laffan.   

Abstract

A 22-year-old male with severe haemophilia A and high responding factor VIII (FVIII) inhibitor underwent sibling haematopoietic stem cell transplantation in an attempt to eradicate the inhibitor. A reduced intensity conditioning regimen was followed by bone marrow infusion and continuous FVIII administration during immune reconstitution. Although substantial levels of FVIII:C (>100 IU dL(-1)) were maintained initially, at day +23 inhibitor titres rose, indicating boosting of recipient memory repertoire, despite complete donor chimerism. On day +46, he developed Klebsiella pneumoniae septicaemia and died. This case shows that, despite very successful transplantation tolerance, the procedure failed to control long-term memory effector immune cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19735311     DOI: 10.1111/j.1365-2516.2009.02099.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  4 in total

Review 1.  Immunomodulation for inhibitors in hemophilia A: the important role of Treg cells.

Authors:  Carol H Miao
Journal:  Expert Rev Hematol       Date:  2010-08       Impact factor: 2.929

2.  The search for the origin of factor VIII synthesis and its impact on therapeutic strategies for hemophilia A.

Authors:  Valder R Arruda
Journal:  Haematologica       Date:  2015-07       Impact factor: 9.941

3.  Role of bone marrow transplantation for correcting hemophilia A in mice.

Authors:  Antonia Follenzi; Sanj Raut; Simone Merlin; Rita Sarkar; Sanjeev Gupta
Journal:  Blood       Date:  2012-02-24       Impact factor: 22.113

Review 4.  Gene therapy for immune tolerance induction in hemophilia with inhibitors.

Authors:  V R Arruda; B J Samelson-Jones
Journal:  J Thromb Haemost       Date:  2016-05-14       Impact factor: 5.824

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.